blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1916301

EP1916301 - METHOD FOR EVALUATING COMPOUND USING MOLECULE ON THE RB PATHWAY AS INDEX AND MOLECULAR DIAGNOSTIC METHOD [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.02.2010
Database last updated on 13.11.2024
Most recent event   Tooltip12.02.2010Application deemed to be withdrawnpublished on 17.03.2010  [2010/11]
Applicant(s)For all designated states
BANYU PHARMACEUTICAL CO., LTD.
Kitanomaru Square 1-13-12, Kudan-kita Chiyoda-ku
Tokyo 102-8667 / JP
[2008/18]
Inventor(s)01 / EGUCHI, Tomohiro, c/o Banyu Pharmaceutical Co., Ltd.
c/o Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki, 300-2611 / JP
02 / KOTANI, Hidehito, c/o Banyu Pharmaceutical Co., Ltd.
c/o Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki, 300-2611 / JP
 [2008/18]
Representative(s)Hussain, Deeba
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2008/18]Hussain, Deeba
Merck & Co., Inc. Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date06782726.108.08.2006
[2008/18]
WO2006JP315992
Priority number, dateJP2005023297111.08.2005         Original published format: JP 2005232971
[2008/18]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007018309
Date:15.02.2007
Language:JA
[2007/07]
Type: A1 Application with search report 
No.:EP1916301
Date:30.04.2008
Language:EN
[2008/18]
Search report(s)International search report - published on:JP15.02.2007
(Supplementary) European search report - dispatched on:EP03.03.2009
ClassificationIPC:C12N15/09, C12Q1/02, C12Q1/68, G01N33/15, G01N33/50, A61K45/00, A61P35/00
[2008/18]
CPC:
G01N33/68 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P43/00 (EP); C12Q1/6886 (EP); G01N33/5008 (EP);
G01N33/5011 (EP); G01N33/502 (EP); G01N33/5091 (EP);
G01N33/574 (EP); C12Q2600/136 (EP) (-)
Designated contracting statesCH,   DE,   FR,   GB,   LI [2008/21]
Former [2008/18]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR BEWERTUNG EINER VERBINDUNG UNTER VERWENDUNG EINES MOLEKÜLS AUF DEM RB-WEG ALS INDEX SOWIE MOLEKULARDIAGNOSTISCHES VERFAHREN[2008/18]
English:METHOD FOR EVALUATING COMPOUND USING MOLECULE ON THE RB PATHWAY AS INDEX AND MOLECULAR DIAGNOSTIC METHOD[2008/18]
French:PROCEDED EVALUATION D UN COMPOSE A L AIDE D UNE MOLECULE SUR LE TRAJET RB COMME INDICE ET PROCEDEDE DIAGNOSTIC MOLECULAIRE[2008/18]
Entry into regional phase13.02.2008Translation filed 
11.03.2008National basic fee paid 
11.03.2008Search fee paid 
11.03.2008Designation fee(s) paid 
11.03.2008Examination fee paid 
Examination procedure13.02.2008Amendment by applicant (claims and/or description)
11.03.2008Examination requested  [2008/18]
12.03.2008Loss of particular rights, legal effect: designated state(s)
21.04.2008Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CY, CZ, DK, EE, ES, FI, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR
08.05.2009Despatch of a communication from the examining division (Time limit: M04)
19.09.2009Application deemed to be withdrawn, date of legal effect  [2010/11]
23.10.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/11]
Fees paidRenewal fee
01.09.2008Renewal fee patent year 03
31.08.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9824935  (UROCOR INC [US], et al) [X] 6-9 * figure 1; example 5 *;
 [X]US2003096781  (MASOOD RIZWAN [US], et al) [X] 6-9 * figures 1,4; examples 1,13 *;
 [X]  - INOUE KEIJI ET AL, "Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer", CANCER RESEARCH, (200004), vol. 60, no. 8, ISSN 0008-5472, pages 2290 - 2299, XP002515599 [X] 1-4 * the whole document *
 [XY]  - BAR-ELI MENASHE, "Role of interleukin-8 in tumor growth and metastasis of human melanoma", PATHOBIOLOGY, KARGER, BASEL, CH, (19990101), vol. 67, no. 1, ISSN 1015-2008, pages 12 - 18, XP009112337 [X] 1-4 * the whole document * [Y] 10-12

DOI:   http://dx.doi.org/10.1159/000028045
 [XY]  - ZHANG HONGQUAN ET AL, "Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression", CELL GROWTH AND DIFFERENTIATION, (199907), vol. 10, no. 7, ISSN 1044-9523, pages 457 - 465, XP009112360 [X] 4 * the whole document * * figure 3 * [Y] 10-12
 [X]  - REN YI ET AL, "Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 DEC 2003, (20031201), vol. 9, no. 16 Pt 1, ISSN 1078-0432, pages 5996 - 6001, XP002515601 [X] 6-9 * figures 1,2; table 3 *
 [X]  - MAIE JOHN A R ST ET AL, "Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma", ARCHIVES OF OTOLARYNGOLOGY HEAD AND NECK SURGERY, AMERICAN MEDICAL ASSOCIATION, US, (20040801), vol. 130, no. 8, ISSN 0886-4470, pages 929 - 935, XP002448845 [X] 6-9 * figures 1,3 *

DOI:   http://dx.doi.org/10.1001/archotol.130.8.929
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.